Fundación De Investigación Biomédica - Hospital Universitario De La Princesa
Clinical trials sponsored by Fundación De Investigación Biomédica - Hospital Universitario De La Princesa, explained in plain language.
-
New app aims to boost allergy treatment adherence
Disease control Recruiting nowThis study tests whether a smartphone app can help people with allergic rhinitis stay on their allergy immunotherapy (allergy shots or drops) for the full 3 years. Many patients stop treatment early, reducing its effectiveness. The app provides reminders and education to improve …
Phase: NA • Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa • Aim: Disease control
Last updated May 17, 2026 02:54 UTC
-
Exercise as medicine: new trial tests if workouts can lift depression
Symptom relief Recruiting nowThis study looks at whether adding a structured exercise program to standard antidepressant treatment can improve symptoms of major depression. Researchers will also use brain scans and blood tests to understand how exercise might reduce inflammation and change brain activity. Ab…
Phase: NA • Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
New study aims to crack the code on Kids' food allergies: treatment or wait?
Knowledge-focused Recruiting nowThis study looks at children aged 4 to 10 with mild to moderate milk or egg allergies. It compares two approaches: oral immunotherapy (OIT) to build tolerance versus simply avoiding the food and waiting for natural recovery. The goal is to find biological markers that predict whi…
Phase: PHASE1, PHASE2 • Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa • Aim: Knowledge-focused
Last updated May 17, 2026 02:53 UTC
-
Migraine mystery solved? scientists hunt for clues to predict treatment success
Knowledge-focused Recruiting nowThis study aims to find ways to predict how well a person with migraine will respond to a class of drugs called anti-CGRP monoclonal antibodies. Researchers will analyze clinical, biological, and brain imaging data from 350 participants aged 18 to 65 with high-frequency or chroni…
Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC